Based on the TTK Healthcare Limited stock forecast from 0 analysts, the average analyst target price for TTK Healthcare Limited is not available over the next 12 months. TTK Healthcare Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of TTK Healthcare Limited is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, TTK Healthcare Limited’s stock price was INR 1,528.45. TTK Healthcare Limited’s stock price has changed by -4.51% over the past week, +1.90% over the past month and +17.64% over the last year.
No recent analyst target price found for TTK Healthcare Limited
No recent average analyst rating found for TTK Healthcare Limited
Company Overview TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. The company's Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. Its Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products under the EVA name; home care products under the Good Home name; sexual wellness products under the Skore name; and air fresheners. The company's Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. Its Protective Devices segment manufactures and markets male contraceptives and other allied products. The company's Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. Its Others segment prints and publishes maps and atlases. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd. Read Less
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. The company's Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, an...Read More
Frequently Asked Questions About TTK Healthcare Limited (TTKHLTCARE:NSE) Stock
Stock Target Advisor's fundamental analysis for TTK Healthcare Limited's stock is Neutral.
TTKHLTCARE:NSE stock's dividend yield is 0.68%.
Our analysis grades TTKHLTCARE:NSE stock's dividend yield at F. This means that TTKHLTCARE:NSE stock's dividend yield is above 50% of the stocks in the Drug Manufacturers - General sector in the NSE exchange.
Based on this TTKHLTCARE:NSE may be a average dividend stock for its sector.
Unfortunately we do not have enough data on TTKHLTCARE:NSE's stock to indicate what its average analyst target is.
TTKHLTCARE:NSE stock's Price/Earning ratio is 32.08.
Our analysis grades TTKHLTCARE:NSE stock's Price / Earning ratio at D. This means that TTKHLTCARE:NSE stock's Price/Earning ratio is above 36% of the stocks in the Drug Manufacturers - General sector in the NSE exchange.
Based on this TTKHLTCARE:NSE may be fairly valued for its sector
The last closing price of TTKHLTCARE:NSE's stock was INR 1,528.45.
The most recent market capitalization for TTKHLTCARE:NSE is INR 20.86B.
Unfortunately we do not have enough analyst data on TTKHLTCARE:NSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains TTK Healthcare Limited's stock.
As per our most recent records TTK Healthcare Limited has 1,294 Employees.
TTK Healthcare Limited's registered address is No.6, Cathedral Road, Chennai, India, 600086.
You can get more information about it from TTK Healthcare Limited's website at https://www.ttkhealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TTKHLTCARE:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
